Form 8.3

Summary by AI BETAClose X

Qube Research & Technologies Limited disclosed on 06-11-2026 that as at 05-11-2026 it holds 5,571,519 cash-settled derivative positions in Bodycote plc representing 3.27% of the 17 3/11p ordinary share class, with 0 direct shares owned (0.00%) and 0 stock-settled derivatives; the filing records multiple equity-swap transactions with a net reduction of 10,077 swap units executed at prices between 917.50 and 919.00 per unit and states there are no indemnities, voting arrangements or subscription rights attached to these positions.

Disclaimer*

Companies

Bodycote (BOY)
UK 100

Latest directors dealings